Search

everythinglearnresearchcommunity

for

Search:↓

Intralesional triamcinolone acetonide is better than PRP for treating scalp alopecia areata, leading to faster and more complete hair regrowth.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Intravenous corticosteroid therapy is effective for long-term hair regrowth in alopecia areata, and a scoring system helps predict treatment success and relapse.

Intralesional triamcinolone acetonide is more effective than platelet-rich plasma for treating scalp alopecia areata.

Alefacept does not effectively treat severe alopecia areata.

Low-dose dutasteride effectively and safely promotes hair growth in men.

The supplement improved hair growth and quality in men with thinning hair and was safe to use.

Growth hormone therapy can improve symptoms and growth in children with Vitamin-D Dependent Rickets Type-2.

New treatments for hair loss, including a compound called "ALRV5XR", platelet-rich plasma, and Adult Stem Cell-based therapy, are showing promise, but more trials are needed for confirmation.

New treatment effectively reverses hair thinning in most patients with mild side effects.

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Diphenylcyclopropenone treatment helps hair growth in alopecia areata by promoting blood vessel growth and cell survival.

TH07 effectively promotes hair regrowth in androgenic alopecia with high patient satisfaction and no major side effects.

Methotrexate and vitamin D3 are potentially more effective and safer than triamcinolone for treating localized alopecia areata.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Combining medication for dyslipidemia and insulin resistance with basic therapy improves outcomes for alopecia areata with metabolic syndrome.

Long-term baricitinib treatment can lead to significant scalp hair regrowth in patients initially showing only eyebrow or eyelash regrowth.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

Hair regrowth from severe alopecia areata treatment with baricitinib can vary, with faster results in those with shorter hair loss duration.

Azathioprine may help treat severe alopecia areata, but more research is needed.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

PRP and microneedling both effectively improve hair growth and thickness for treating hair loss.

JAK inhibitors effectively regrow hair in children with alopecia areata and are safe to use.

Clinical trials for alopecia areata need better inclusion and retention of patients of color.

Abrocitinib effectively treats severe alopecia areata with significant improvement and no side effects.